Related Experiment Videos
The complete sequence of human preprocalcitonin
FEBS Letters
|February 13, 1984
Summary
Researchers synthesized complementary DNA from thyroid cancer mRNA to determine the full amino acid sequence of human preprocalcitonin. This advancement aids in understanding calcitonin production in medullary thyroid carcinoma.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Medullary thyroid carcinoma (MCT) is a calcitonin-producing tumor.
- Understanding the molecular basis of MCT requires characterizing calcitonin precursors.
Purpose of the Study:
- To clone and sequence the complementary DNA (cDNA) encoding human preprocalcitonin.
- To deduce the complete amino acid sequence of human preprocalcitonin.
Main Methods:
- Extraction of mRNA from thyroid carcinoma tissue.
- Construction of a recombinant plasmid containing cDNA insert using G-C tailing.
- Transformation of Escherichia coli and screening of ampicillin-resistant clones.
- Hybridization screening using radiolabeled probes and in vitro translation.
- DNA sequencing of positive clones.
Main Results:
- A cDNA insert of 426 bp encoding the entire coding region was isolated.
- The insert contained 70 bp at the 5'-end and 295 bp upstream of the poly(A) tail.
- Restriction sites were compatible with previously published rat calcitonin mRNA sequences.
- The complete amino acid sequence of human preprocalcitonin was deduced.
Conclusions:
- The study successfully cloned and sequenced the full-length cDNA for human preprocalcitonin.
- This provides the complete amino acid sequence, crucial for understanding MCT pathogenesis.
- The findings facilitate further research into calcitonin biology and related disorders.